| Ident. | Authors (with country if any) | Title |
|---|
| 000184 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000185 (2020) |
Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde] | Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. |
| 000331 (2020) |
Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde] | Recent discovery and development of inhibitors targeting coronaviruses |
| 000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000655 (2020) |
Abdul Mannan Baig [Pakistan] ; Areeba Khaleeq [Pakistan] ; Usman Ali [Pakistan] ; Hira Syeda [Pakistan] | Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. |
| 000720 (2020) |
Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. |
| 000736 (2020) |
Gun-Soo Park [Corée du Sud] ; Keunbon Ku [Corée du Sud] ; Seung-Hwa Baek [Corée du Sud] ; Seong-Jun Kim [Corée du Sud] ; Seung Il Kim [Corée du Sud] ; Bum-Tae Kim [Corée du Sud] ; Jin-Soo Maeng [Corée du Sud] | Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2 |
| 000B90 (2019) |
Shuai Xia [République populaire de Chine] ; Lei Yan [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Anurodh Shankar Agrawal [États-Unis] ; Abdullah Algaissi [États-Unis, Arabie saoudite] ; Chien-Te K. Tseng [États-Unis] ; Qian Wang [République populaire de Chine] ; Lanying Du [États-Unis] ; Wenjie Tan [République populaire de Chine] ; Ian A. Wilson [République populaire de Chine, États-Unis] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Bei Yang [République populaire de Chine] ; Lu Lu [République populaire de Chine] | A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike |
| 000C59 (2018) |
Luca Sancineto [Pologne] ; Nunzio Iraci [Italie] ; Oriana Tabarrini [Italie] ; Claudio Santi [Italie] | NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors. |
| 000D34 (2017) |
Justine Desroches [France] ; Charline Kieffer [France] ; Nicolas Primas [France] ; Sébastien Hutter [France] ; Armand Gellis [France] ; Hussein El-Kashef [Égypte] ; Pascal Rathelot [France] ; Pierre Verhaeghe [France] ; Nadine Azas [France] ; Patrice Vanelle [France] | Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold |
| 000D56 (2017) |
Md. Abdul Alim Al-Bari | Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |
| 000D57 (2017) |
Cheng-Wei Yang [République populaire de Chine] ; Yue-Zhi Lee [République populaire de Chine] ; Hsing-Yu Hsu [République populaire de Chine] ; Chuan Shih [République populaire de Chine] ; Yu-Sheng Chao [République populaire de Chine] ; Hwan-You Chang [République populaire de Chine] ; Shiow-Ju Lee [République populaire de Chine] | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. |
| 000E17 (2017) |
Ya-Li Sang ; Wei-Ming Zhang [République populaire de Chine] ; Peng-Cheng Lv ; Hai-Liang Zhu [République populaire de Chine] | Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization. |
| 000E56 (2017) |
Jibin Sadasivan [Inde] ; Manmeet Singh ; Jayasri Das Sarma | Cytoplasmic tail of coronavirus spike protein has intracellular targeting signals. |
| 000F54 (2016) |
Haofeng Wang ; Song Xue ; Haitao Yang ; Cheng Chen | Recent progress in the discovery of inhibitors targeting coronavirus proteases |
| 000F94 (2016) |
Oi-Wing Ng [Singapour] ; Adeline Chia [Singapour] ; Anthony T. Tan [Singapour] ; Ramesh S. Jadi [Singapour] ; Hoe Nam Leong [Singapour] ; Antonio Bertoletti [Singapour] ; Yee-Joo Tan [Singapour] | Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. |
| 001051 (2016) |
Qing Meng [République populaire de Chine] ; Xuwang Chen [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Wenxin Li [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket. |
| 001052 (2016) |
Jiapei Yang [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Xueyi Lu [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Zhaoqiang Liu [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Christophe Pannecouque [Belgique] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket. |
| 001107 (2016) |
Thomas Hermann [États-Unis] | Small molecules targeting viral RNA |
| 001122 (2016) |
Lanjun Zhang [République populaire de Chine] ; Guolong Huang [République populaire de Chine] ; Qixu Cai [République populaire de Chine] ; Chen Zhao [République populaire de Chine] ; Liuyun Tang [République populaire de Chine] ; Haixia Ren [République populaire de Chine] ; Peng Li [République populaire de Chine] ; Ning Li [République populaire de Chine] ; Jianwei Huang [République populaire de Chine] ; Xueqin Chen [République populaire de Chine] ; Yi Guan [République populaire de Chine] ; Han You [République populaire de Chine] ; Shuhui Chen [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Tianwei Lin [République populaire de Chine] | Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71 |
| 001227 (2015) |
Sarah E. St. John [États-Unis] ; Sakshi Tomar [États-Unis] ; Shaun R. Stauffer [États-Unis] ; Andrew D. Mesecar [États-Unis] | Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS) |
